A New Covid Shot from Novavax Will Test Americans’ Appetite for Vaccines
A health-care worker prepares a syringe of the Novavax Covid-19 vaccine.
Photographer: Liesa Johannssen-Koppitz/BloombergGood morning, Fiona in New York here. This week 3.2 million doses of Novavax’s Covid vaccine became available to Americans. Will people sign up? But first...
It’s been two-and-half years since the outbreak of Covid-19, and Novavax is just joining the US vaccine drive. The bio-tech company based near Washington, D.C., took longer than others to develop its shot, slowed by manufacturing delays. But last week the government finally gave clearance to distribute its Covid-19 vaccine.